Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „bosutinib“
Suchtreffer
Begriffe & Kennungen
Bosulif · 4.5 · 10 increased bosutinib Cmax by 1.5-fold, and bosutinib AUC in plasma by 2.0-fold, as compared with administrat
Eintrag öffnenBosulif · 4.5 · Anti-arrhythmic medicinal products and other substances that may prolong QT Bosutinib should be used with caut
Eintrag öffnenBosulif · 4.5 · Based on the large reduction in bosutinib exposure that occurred when bosutinib was co-administered with rifam
Eintrag öffnenBosulif · 4.5 · CYP3A inducers The concomitant use of bosutinib with strong CYP3A inducers (including, but not limited to carb
Eintrag öffnenBosulif · 4.5 · CYP3A inhibitors The concomitant use of bosutinib with strong CYP3A inhibitors (including, but not limited to
Eintrag öffnenBosulif · 4.5 · Caution is warranted if mild CYP3A inducers are used concomitantly with bosutinib.
Eintrag öffnenBosulif · 4.5 · Caution should be exercised if mild CYP3A inhibitors are used concomitantly with bosutinib.
Eintrag öffnenBosulif · 4.5 · Effects of bosutinib on other medicinal products
Eintrag öffnenBosulif · 4.5 · Effects of other medicinal products on bosutinib
Eintrag öffnenBosulif · 4.5 · Following concomitant administration of a single dose bosutinib with 6 daily doses of 600 mg rifampicin, in 24
Eintrag öffnenBosulif · 4.5 · If a strong or moderate CYP3A inhibitor must be administered during bosutinib treatment, an interruption of bo
Eintrag öffnenBosulif · 4.5 · In a study of 27 healthy subjects, in whom a single dose of 500 mg bosutinib was co-administered with a single
Eintrag öffnenBosulif · 4.5 · In vitro studies indicate that bosutinib has a low potential to inhibit breast cancer resistance protein (BCRP
Eintrag öffnenBosulif · 4.5 · Proton pump inhibitors (PPIs) Caution should be exercised when administering bosutinib concomitantly with PPIs
Eintrag öffnenBosulif · 4.8 · A total of 1 372 leukaemia adult patients received at least 1 dose of single-agent bosutinib. The median durat
Eintrag öffnenBosulif · 4.8 · A total of 55 paediatric patients ≥ 1 year of age received at least 1 dose of bosutinib in the Phase I/II, mul
Eintrag öffnenBosulif · 4.8 · Table 4 – Adverse reactions for bosutinib
Eintrag öffnenbosutinib
Eintrag öffnenbosutinib (as monohydrate)
Eintrag öffnenbosutinib monohydrate
Eintrag öffnen